Phase II study of oral idarubicin in patients with AIDS-associated Kaposi's sarcoma.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D003630:Daunorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015255:Idarubicin; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012514:Sarcoma, Kaposi / Q000150:complications / Q000188:drug therapy* / Q000473:pathology
D015255:Idarubicin; D003630:Daunorubicin